MAPT and Alzheimer disease: Further, as mentioned, younger individuals with symptomatic AD had higher tau PET load in brain regions being affected later in the disease process as well as lower tau368/t-tau, whereas this was not the case for p-tau181, p-tau217, and t-tau.